Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5174330
Max Phase: Preclinical
Molecular Formula: C40H59N11O14S2
Molecular Weight: 982.11
Associated Items:
ID: ALA5174330
Max Phase: Preclinical
Molecular Formula: C40H59N11O14S2
Molecular Weight: 982.11
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSCC(=O)CSC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C40H59N11O14S2/c1-20(52)32-37(62)47-24(4-2-12-44-40(42)43)33(58)46-25(10-11-31(56)57)34(59)48-26(14-21-6-8-22(53)9-7-21)38(63)51-13-3-5-29(51)36(61)49-28(39(64)65)19-67-17-23(54)16-66-18-27(35(60)50-32)45-30(55)15-41/h6-9,20,24-29,32,52-53H,2-5,10-19,41H2,1H3,(H,45,55)(H,46,58)(H,47,62)(H,48,59)(H,49,61)(H,50,60)(H,56,57)(H,64,65)(H4,42,43,44)/t20-,24+,25+,26+,27+,28+,29+,32+/m1/s1
Standard InChI Key: PIGMBPQXPNECHU-VOYJGBGOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 982.11 | Molecular Weight (Monoisotopic): 981.3684 | AlogP: -4.56 | #Rotatable Bonds: 13 |
Polar Surface Area: 414.96 | Molecular Species: ZWITTERION | HBA: 16 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 25 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.47 | CX Basic pKa: 12.15 | CX LogP: -9.32 | CX LogD: -9.50 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.05 | Np Likeness Score: 0.76 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):